# Exploratory Study of Additional Use of Scopolamine Butylbromide, Glucagon or NPO-11 Following Single Dose of NPO-11 in Healthy Adult Men

> **NCT00740324** · PHASE3 · COMPLETED · sponsor: **Nihon Pharmaceutical Co., Ltd** · enrollment: 30 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** NPO-11
- **DRUG:** NPO-11
- **DRUG:** NPO-11

## Key facts

- **NCT ID:** NCT00740324
- **Lead sponsor:** Nihon Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2009-03
- **Final completion:** 2009-07
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2010-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00740324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00740324, "Exploratory Study of Additional Use of Scopolamine Butylbromide, Glucagon or NPO-11 Following Single Dose of NPO-11 in Healthy Adult Men". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00740324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*